| 16:30 – 16:40 | Introducción |
Miguel Martín, Hospital General Universitario Gregorio Marañón, Madrid, Spain Francisco Ayala, Hospital General Universitario Gregorio Marañón, Madrid, Spain |
16:40 – 18:20
SESIÓN 1:
General Topic
| Chair: | Francisco Ayala, Hospital General Universitario Gregorio Marañón, Madrid |
| 16:40 - 17:00 | Beyond five years: clinical and genomic predictors of late recurrence in HR+/HER2- early breast cancer Michael Gnant, Comprehensive Cancer Center - Medical University of Vienna, Austria |
| 17:00 - 17:10 | Discussion |
| 17:10 - 17:30 | Should nodal irradiation replace axillary surgery? Philip Poortmans, University of Antwerp, Belgium |
| 17:30 - 17:50 | AI-based histopathology as a prognostic tool in early breast cancer Calvin Chao, ArteraAI, California, USA |
| 17:50 - 18:10 | Special situations in breast cancer Francisco Ayala, Hospital General Universitario Gregorio Marañón, Madrid, Spain |
| 18:10 - 18:20 | Discussion |
| 18:20 - 18:30 | Break |
18:30 – 20:10
SESIÓN 2:
Therapy 1
| Chair: | Luis Costa, Hospital de Santa Maria in Lisbon, Portugal |
| 18:30 - 19:00 | Maximising patient benefit from adjuvant CDK4/6 inhibitors Michael Untch, Helios Hospital Berlin-Buch, Germany |
| 19:00 - 19:20 | Identification of lower-risk triple negative subsets for therapy descalation Maria Vittoria Dieci, Professor at University of Padua, Italy |
| 19:20 - 19:40 | A differential adjuvant strategy for early lobular breast cancer? Sherry Shen, Memorial Sloan Kettering Cancer Center, New York, USA |
| 19:40 - 20:00 | Discussion |